2D Thermal Proteome Profiling (2D-TPP) Service for Target Deconvolution

Q: How do your bioinformatics pipelines control the false positive rate in 2D-TPP data?

We utilize advanced statistical curve-fitting algorithms that require a mathematically sound, dose-dependent response across the entire concentration gradient.

Accelerate your target identification and mechanism-of-action studies with our high-throughput, label-free 2D Thermal Proteome Profiling (2D-TPP) service.

When conducting phenotypic screens or investigating unexplained toxicity, finding the exact protein target is often the hardest part of drug discovery. Traditional methods frequently force you to modify your active compounds with bulky chemical probes, which can alter how the drug behaves or completely kill its activity. At Creative Proteomics, we help you bypass this bottleneck.

Our 2D-TPP service enables you to evaluate compound–target interactions and screen for off-target effects directly in living cells. By combining multiplexed high-resolution mass spectrometry with rigorous, statistically robust curve-fitting algorithms, we deliver high-confidence, actionable data that helps you minimize false positives and move your pipeline forward.

Request a Project Consultation

2D Thermal Proteome Profiling (2D-TPP) service workflow matrix including concentration and temperature gradients.

What Is 2D-TPP Service Overview Workflow Instrumentation Technology Comparison Sample Demo Results Case Study FAQ

What Is 2D Thermal Proteome Profiling (2D-TPP)?

2D Thermal Proteome Profiling (2D-TPP) is an advanced, probe-free mass spectrometry technique designed to monitor drug-protein interactions across the entire proteome in a near-native physiological environment.

The core principle relies on the fact that when a drug binds to a protein, it typically stabilizes that protein against heat-induced unfolding. While standard Thermal Proteome Profiling (TPP) usually looks at a single drug concentration across various temperatures, 2D-TPP introduces a critical second dimension. We expose the living cells to a concentration gradient of your compound across a temperature gradient.

This two-dimensional matrix allows us to observe true dose-dependent thermal stabilization. By capturing exactly how a protein's melting behavior shifts incrementally as the drug concentration increases, we can confidently differentiate genuine binding events from random background noise, non-specific aggregation, or biological artifacts.

Why It Matters for Your Research:

True Label-Free Engagement: You do not need to synthesize complex click-chemistry probes or attach bulky biotin tags. We test the exact, unmodified small molecule you plan to advance into the clinic.
Native Context: We perform the assay in intact living cells, preserving critical protein-protein complexes, delicate membrane associations, and natural 3D folding states that recombinant assays destroy.
Deep Proteome Coverage: Utilizing state-of-the-art mass spectrometry, we can simultaneously track thousands of cellular proteins to find hidden off-targets that might cause downstream toxicity or adverse phenotypic effects.

Service Overview – Creative Proteomics 2D-TPP Capabilities

We have optimized our 2D-TPP platform to address the most pressing, time-consuming challenges in early-stage drug discovery. Depending on your specific developmental roadblocks, our tailored screening modes include:

MODE 1

Target Deconvolution for Phenotypic Hits

If you have discovered a highly active compound in a phenotypic screen but do not know its mechanism of action, we use 2D-TPP to scan the cellular proteome and identify its primary direct binding partners.

MODE 2

Off-Target Toxicity Profiling

When a promising lead shows unexpected side effects or narrow safety margins, we map its full interaction network to pinpoint secondary off-targets, helping you guide your medicinal chemistry optimization to design out the toxicity.

MODE 3

Membrane Protein Engagement

Membrane proteins are notoriously difficult to study using standard biochemical pull-down assays. Because 2D-TPP operates seamlessly in living cells or gentle physiological lysates, we can successfully capture binding events on integral membrane receptors, transporters, and ion channels.

MODE 4

Advanced Curve-Fitting & Hit Ranking

Generating massive proteomics data sets is only half the battle; interpreting them is the real challenge. We provide robust biostatistical scoring to rank your hits based on dose-response thermal shifts, cutting through the noise so you only spend time and resources validating real, high-confidence targets.

2D-TPP Workflow & Rigorous QC Checkpoints

Our workflow is meticulously designed to maximize data quality and strictly control false discovery rates at every stage.

Target-Compound Incubation in Live Cells

We incubate your unmodified compound with living cells (or carefully prepared tissue lysates) across a carefully designed concentration gradient. This ensures the drug naturally penetrates the cell membrane and interacts with targets in their actual physiological state, competing with endogenous metabolites.

2D Matrix Heating

The treated cells are divided into distinct aliquots and subjected to a range of temperatures using highly precise gradient thermal cyclers. This creates a dense matrix of samples representing varying drug doses at varying unfolding temperatures.

Multiplexed TMT Labeling & High-Resolution MS

To eliminate run-to-run quantitative variability and ensure highly accurate comparisons across the entire matrix, we extract the soluble (non-denatured) proteins and label them with isobaric Tandem Mass Tags (TMT). The multiplexed samples are then pooled and analyzed using our advanced Thermal Shift Proteomics platforms.

Rigorous QC & Bioinformatics Filtering

This is where our service distinctly stands out. We do not just hand you an unfiltered list of proteins. Our specialized computational pipelines fit non-linear thermal melting curves to the raw data, applying strict statistical thresholds (p-values and false discovery rates) to isolate proteins that show a mathematically sound, dose-dependent shift in thermal stability.

2D-TPP experimental design matrix combining temperature and concentration gradients.

Applications: When to Choose 2D-TPP

2D-TPP is the ideal analytical solution when conventional screening or target identification methods hit a wall. We highly recommend leveraging this service for the following research scenarios:

When Probe Synthesis Alters Activity

If adding a linker, fluorophore, or affinity tag to your small molecule destroys its cellular permeability or significantly alters its binding affinity, 2D-TPP provides a completely label-free alternative that respects the drug's true chemical properties.

When Phenotypic Screens Yield Unknown Targets

You know your drug kills specific cancer cells or stops viral replication, but you do not know the underlying mechanism. 2D-TPP acts as a powerful, unbiased fishing net to find the responsible target without any preconceived hypotheses.

When Toxicity Arises from Unknown Off-Targets

If an advanced lead compound is causing unexplained toxicity or adverse events in animal models, 2D-TPP can comprehensively map all the proteins the drug is accidentally binding to, revealing the molecular basis of the toxicity.

When Repurposing Old Drugs

If you are exploring a well-known, clinically approved drug for a completely new disease indication, 2D-TPP can uncover previously undocumented, novel mechanisms of action that explain its new therapeutic efficacy.

Platform Instrumentation

At Creative Proteomics, we rely exclusively on industry-leading instrumentation to ensure maximum sensitivity, high reproducibility, and massive data throughput required for proteome-wide profiling.

Module Category	Instrument / System	Core Capability	Why It Matters
Heating Matrix	High-precision gradient thermal cyclers	Exacting sub-degree temperature control	Ensures highly reproducible protein melting curves across all sample aliquots, minimizing technical variance.
LC Separation	Nano-UPLC systems	Ultra-high performance liquid chromatography	Achieves deep peptide fractionation for maximum proteome coverage, enabling the capture of critical low-abundance targets.
Mass Spectrometry	High-resolution MS (e.g., Orbitrap/Q-TOF series)	Unmatched mass accuracy and fast scanning speeds	Confidently identifies and precisely quantifies thousands of TMT-labeled peptides simultaneously without reporter ion interference.
Informatics	Cloud-based statistical curve-fitting algorithms	Automated, high-throughput dose-response analysis	Instantly separates true dose-dependent binding events from background biological noise and thermal aggregation.

Technology Comparison: 2D-TPP vs. Alternative Techniques

Selecting the right mass spectrometry technique is crucial for your project's success and budget. Here is how 2D-TPP compares to other popular target discovery methods.

Technique	Core Principle	Key Strengths	Key Limitations
2D-TPP	Matrix heating (dose + temp gradients) followed by MS	Provides label-free, true dose-response confidence; unparalleled for unbiased off-target profiling.	Generates massive, complex datasets requiring advanced computational curve-fitting expertise.
1D-TPP	Single-dose heating followed by MS	Simpler experimental design; excellent for rapidly validating engagement on a known, primary target.	Misses the critical nuances of concentration-dependent binding; carries a higher risk of false positives for unknown targets.
ABPP-MS	Reactive chemical probes followed by MS	Identifies the exact specific binding residues; extremely high sensitivity for covalent interactions.	Requires difficult and expensive probe synthesis; chemical tags can fundamentally alter the drug’s natural biological activity.

Choosing Your Strategy:

Choose 2D-TPP for untargeted dose-response profiling, comprehensive off-target discovery, and when you absolutely cannot or will not chemically modify your screening hit.
Opt for 1D-TPP when you simply need to evaluate whether your drug hits its intended, known target at a specific, single physiological dose.
Select ABPP-MS when you are specifically investigating reactive residues (like covalent inhibitors) and already have access to established, well-validated chemical probes.

Sample Requirements

To ensure the highest quality quantitative data, we require all incoming samples to meet specific baseline criteria. Please refer to our general submission guidelines below.

Sample Type	Required Amount	Preparation & Storage Condition	Notes
Live Cells	1 × 10⁷ to 5 × 10⁷ cells per condition	Flash-frozen cell pellets (store at -80°C)	Wash thoroughly with cold PBS before freezing to remove all media and serum proteins.
Tissues	50–100 mg (wet weight)	Flash-frozen in liquid nitrogen immediately upon harvest	Avoid any repeated freeze-thaw cycles to strictly preserve native protein structures and complexes.
Protein Extracts / Lysates	1–5 mg total protein	Shipped on dry ice	Verify total protein concentration via BCA or Bradford assay prior to shipping to ensure adequate input.

Deliverables & Demo Results

We firmly believe in complete data transparency. When your 2D-TPP project is complete, you will receive much more than just a raw data dump; you receive structured, actionable insights that are immediately ready for your next critical lab or board meeting.

Demo results: Thermal melting curve visualization and statistical target engagement scoring.

Example 2D-TPP Thermal Stabilization Curve

Fitted curve visualizations demonstrating concentration-dependent thermal stabilization, providing visual proof of engagement.

Minimum Standard Deliverables:

Ranked List of Hits: A clean, structurally formatted Excel table of all identified proteins, rigorously ranked by their thermal shift magnitude (ΔTm) and statistical confidence.
Thermal Melt Curve Plots: High-quality visualizations of the dose-dependent stabilization curves for your top statistically significant targets.
Statistical Scoring: Detailed p-values and False Discovery Rate (FDR) metrics for every identified protein.
Raw MS Spectra Files: Complete raw mass spectrometry data files provided for internal archiving or re-analysis.

Case Study: Identifying Novel Off-Targets via 2D-TPP

Kurzawa et al. (2020) “A computational method for detection of ligand-binding proteins from dose range thermal proteome profiles.” Nature Communications 11, 5783. https://doi.org/10.1038/s41467-020-19529-8

Background

Detecting precise off-target interactions of epigenetic drugs inside living cells is absolutely critical for understanding clinical drug toxicity. Traditional methods often struggle with untargeted, proteome-wide profiling without permanently modifying the drug structure, which can introduce massive artifacts. In a highly cited, landmark study, researchers utilized 2D-TPP to seamlessly map the full proteomic interactome of the HDAC8 inhibitor PCI-34051.

Methods

Live cells were treated with a wide concentration gradient of the inhibitor PCI-34051 across an equally expansive gradient of temperatures. The soluble protein fractions were subsequently labeled with multiplexed TMT reagents and analyzed via quantitative LC-MS/MS to construct a highly detailed, comprehensive dose-range thermal profile matrix.

Results

Using rigorous, non-linear curve-fitting algorithms designed to process the 2D matrix, the researchers successfully verified engagement with the primary known target (HDAC8) with a distinct dose-response stabilization. More importantly, as clearly demonstrated in Figure 4 of the referenced study, the dose-range thermal profiling confidently identified leucine aminopeptidase 3 (LAP3) as a direct, previously entirely unknown off-target of the drug. The data showed distinct, concentration-dependent thermal stabilization curves for LAP3 achieving a calculated EC50 of stabilization.

Conclusions

2D-TPP successfully deconvoluted the complex off-target landscape of the inhibitor in a completely label-free, physiologically relevant manner. This elegantly demonstrates the immense power of 2D-TPP in safety profiling, toxicity prediction, and uncovering hidden mechanisms of action without the need for synthetic chemistry interventions.

2D-TPP case study results discovering LAP3 off-target showing thermal stabilization curves.

Identification of LAP3 as an off-target using 2D-TPP (Figure 4, Reference: Kurzawa et al., 2020).

FAQ

Frequently Asked Questions

Q: Does 2D-TPP require any chemical modification of my screening hits?

No. 2D-TPP is a completely label-free assay. You provide the unmodified parent compound, and we test it exactly as it is, ensuring we capture its true native binding affinity and cellular permeability.

Q: How do your bioinformatics pipelines control the false positive rate in 2D-TPP data?

Because heating cells can cause random protein precipitation, we utilize advanced statistical curve-fitting algorithms. We do not just look for a single temperature shift; we require a mathematically sound, dose-dependent response across the entire concentration gradient. This dual-validation significantly filters out background noise and limits false positives.

Q: Can this service be performed on tissue samples instead of cell lines?

Yes. While live cultured cells are the most common input, 2D-TPP can be effectively adapted for tissue lysates and flash-frozen tissue samples, allowing you to study drug engagement in more complex, in vivo-like physiological models.

Reference

Kurzawa, N., Becher, I., et al. A computational method for detection of ligand-binding proteins from dose range thermal proteome profiles. Nat Commun 11, 5783 (2020).
Franken, H., Mathieson, T., et al. Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes. Nat Protoc (2015).
Savitski, M. M., et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science (2014).

Plan a 2D-TPP campaign with the MassTarget™ team

Share your target and drug details and our scientists will design a tailored 2D-TPP screening strategy for your discovery program.

Request a Project Consultation

Disclaimer: All services and products offered by Creative Proteomics are for Research Use Only (RUO). They are not intended for use in diagnostic procedures, clinical decision-making, or any therapeutic applications. We do not provide medical advice or clinical diagnostic conclusions.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.